These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24588063)

  • 21. Explicit and Implicit Measures of Identity Diffusion in Adolescent Girls With Borderline Personality Disorder.
    Plakolm Erlač S; Bucik V; Gregorič Kumperščak H
    Front Psychiatry; 2021; 12():805390. PubMed ID: 35046857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of the Borderline Symptom List to DSM-IV borderline personality disorder criteria assessed by semi-structured interview.
    Glenn CR; Weinberg A; Klonsky ED
    Psychopathology; 2009; 42(6):394-8. PubMed ID: 19776670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Convergence between DSM-5 Section II and Section III diagnostic criteria for borderline personality disorder.
    Sellbom M; Sansone RA; Songer DA; Anderson JL
    Aust N Z J Psychiatry; 2014 Apr; 48(4):325-32. PubMed ID: 24253360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology.
    Zanarini MC; Vujanovic AA; Parachini EA; Boulanger JL; Frankenburg FR; Hennen J
    J Pers Disord; 2003 Jun; 17(3):233-42. PubMed ID: 12839102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Borderline personality traits and disorder: predicting prospective patient functioning.
    Hopwood CJ; Zanarini MC
    J Consult Clin Psychol; 2010 Aug; 78(4):585-9. PubMed ID: 20658814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The validity of the MSI-BPD among inpatient adolescents.
    Noblin JL; Venta A; Sharp C
    Assessment; 2014 Apr; 21(2):210-7. PubMed ID: 23344914
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Sharp C; Steinberg L; Michonski J; Kalpakci A; Fowler C; Frueh BC; Fonagy P
    Assessment; 2019 Sep; 26(6):1014-1029. PubMed ID: 30003799
    [No Abstract]   [Full Text] [Related]  

  • 28. Development and validation of the Minnesota borderline personality disorder scale.
    Bornovalova MA; Hicks BM; Patrick CJ; Iacono WG; McGue M
    Assessment; 2011 Jun; 18(2):234-52. PubMed ID: 21467094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construct validity and prevalence rate of borderline personality disorder among Chinese adolescents.
    Leung SW; Leung F
    J Pers Disord; 2009 Oct; 23(5):494-513. PubMed ID: 19817630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypermentalizing in adolescent inpatients: treatment effects and association with borderline traits.
    Sharp C; Ha C; Carbone C; Kim S; Perry K; Williams L; Fonagy P
    J Pers Disord; 2013 Feb; 27(1):3-18. PubMed ID: 23342954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construct Validity of the DSM-5 Section III Personality Trait Profile for Borderline Personality Disorder.
    Anderson JL; Sellbom M
    J Pers Assess; 2015; 97(5):478-86. PubMed ID: 26061018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Validity of the World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition in Adolescence.
    Somma A; Adler LA; Gialdi G; Arteconi M; Cotilli E; Fossati A
    J Child Adolesc Psychopharmacol; 2021 Nov; 31(9):631-638. PubMed ID: 34166067
    [No Abstract]   [Full Text] [Related]  

  • 33. The BPQ: a scale for the assessment of borderline personality based on DSM-IV criteria.
    Poreh AM; Rawlings D; Claridge G; Freeman JL; Faulkner C; Shelton C
    J Pers Disord; 2006 Jun; 20(3):247-60. PubMed ID: 16776554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of the Spanish version of the McLean Screening Instrument for Borderline Personality Disorder.
    Soler J; Domínguez-Clavé E; García-Rizo C; Vega D; Elices M; Martín-Blanco A; Feliu-Soler A; Carmona C; Pascual JC
    Rev Psiquiatr Salud Ment; 2016; 9(4):195-202. PubMed ID: 27067102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Screening measure for borderline personality disorder].
    Kröger C; Vonau M; Kliem S; Kosfelder J
    Psychother Psychosom Med Psychol; 2010; 60(9-10):391-6. PubMed ID: 20225166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing the Personality Disorder Interview for DSM-IV (PDI-IV) and SCID-II borderline personality disorder scales: an item-response theory analysis.
    Huprich SK; Paggeot AV; Samuel DB
    J Pers Assess; 2015; 97(1):13-21. PubMed ID: 25203418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of the hyperbolic temperament questionnaire in Iran.
    Komasi S; Chamandoost Z; Vaysi A; Amirian M; Rezaeean H; Hopwood CJ
    BMC Psychol; 2023 Oct; 11(1):307. PubMed ID: 37798773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New tricks for an old measure: the development of the Barratt Impulsiveness Scale-Brief (BIS-Brief).
    Steinberg L; Sharp C; Stanford MS; Tharp AT
    Psychol Assess; 2013 Mar; 25(1):216-26. PubMed ID: 23148649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Borderline Syndrome Index. Clinical validity and utility.
    Edell WS
    J Nerv Ment Dis; 1984 May; 172(5):254-63. PubMed ID: 6716090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age differences in DSM-IV borderline personality disorder symptom expression: Results from a national study using item response theory (IRT).
    McMahon K; Hoertel N; Peyre H; Blanco C; Fang C; Limosin F
    J Psychiatr Res; 2019 Mar; 110():16-23. PubMed ID: 30579046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.